Q3SNG2 AF NFT

Ribulose bisphosphate carboxylase large chain 2

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeieoxm7bsb5tqeat4eyaoexf42ddp2aewpnm4jx4ljacgasumch7eq/metadata.json
IPFS of structure file: 
bafybeif4zfambgkmxdx7dpscbh4olzfq34xqgmofa4b3hx2triekvjy2ta/AF-Q3SNG2-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x67Caacc81C91Ffe8C5b6E9623969278a00FCc789
First NFT owner address (bech32): 
genesis1vl92ejquj8l733dka93rj6f83gq0e3ufu8rlpk
Current NFT ID #333938 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
333938
Accession (UniProt):
Q3SNG2
Name::
Ribulose bisphosphate carboxylase large chain 2
Experimental Method:
Predicted structure
Sequence source:
Nitrobacter winogradskyi (strain ATCC 25391 / DSM 10237 / CIP 104748 / NCIMB 11846 / Nb-255)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q3SNG2 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q3SNG2|RBL1B_NITWN Ribulose bisphosphate carboxylase large chain 2 OS=Nitrobacter winogradskyi (strain ATCC 25391 / DSM 10237 / CIP 104748 / NCIMB 11846 / Nb-255) OX=323098 GN=cbbL2 PE=3 SV=1 MNVQNEKSMTVRGKDRYKSGVMSYKKMGYWEPDYTPKDTDVICLFRVTPQDGVDPIEASAAVAGESSTATWTVVWTDRLTAAEKYRAKCYRVDPVPGAEGQYFAYIAYDLDLFEPGSISNLTASVIGNVFGFKPLKALRLEDMRLPVAYVKTFKGPPTGIVVERERLDKFGRPLLGATVKPKLGLSGRNYGRVVYEALKGGLDFTKDDENINSQPFMHWRERFLYCMEAVNRAQAATGEIKGSYLNVTAATMEDMYERAEFAKELGSVVVMIDLVIGYTAIQSMSNWARKNDMILHLHRAGHSTYTRQRSHGVSFRVISKWMRLAGVDHIHAGTVVGKLEGDPLTTRGFYDICREEYNPTQLEHGIFFDQNWASLNKVMPVASGGIHAGQMHQLIQHLGEDVVLQFGGGTIGHPMGIQAGATANRVALEAMILARNEGRDYVSEGPEILAKAAASCTPLKQALEVWKDVTFDYASTDAPDYVPTAVPAA